Tag: Alzheimer’s disease
Diabetes and Dementia: New Evidence Reveals Bidirectional Risk and Potential Neuroprotection
Mounting evidence reveals that diabetes and dementia share bidirectional pathophysiological pathways involving impaired glucose metabolism, chronic inflammation, and vascular dysfunction.…
Glucosamine Supplements May Accelerate Memory Loss in Alzheimer’s Disease, New Research Warns
New research combining animal studies and patient records suggests glucosamine supplements may accelerate memory decline in Alzheimer's patients while remaining…
Popular Joint Supplement Glucosamine Linked to 25% Higher Alzheimer’s Risk
New research finds glucosamine supplement users face 25% higher risk of progressing from mild cognitive impairment to Alzheimer's disease. The…
Popular Joint Pain Supplement Glucosamine Linked to Accelerated Dementia Risk
University of Florida research reveals concerning association between glucosamine supplements and accelerated progression from mild cognitive impairment to Alzheimer's disease.…
Blood Cancer Gene Mutations Trigger Alzheimer’s Disease Through Brain Inflammation
New research reveals blood cancer-associated genetic mutations in 43% of Alzheimer's patients, creating inflammatory brain cells that accelerate neurodegeneration. The…
New Drug Target for Alzheimer’s Shows Promise in Preclinical Studies
Researchers identified a novel Alzheimer's mechanism and developed an experimental compound that slowed nerve cell loss in mouse models. The…
USC researchers identify enzyme target for reducing Alzheimer’s brain inflammation
USC researchers have identified a new approach to combat Alzheimer's by targeting the cPLA2 enzyme that drives brain inflammation. The…
Molecular Switch Driving Alzheimer’s Brain Inflammation Identified by Scripps Research
Scripps Research scientists have identified a molecular switch involving STING protein modifications that drives chronic brain inflammation in Alzheimer's disease.…